These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2578724)

  • 1. Calcium-channel blockers: effects on cerebral blood flow and potential uses for acute stroke.
    Gelmers HJ
    Am J Cardiol; 1985 Jan; 55(3):144B-148B. PubMed ID: 2578724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of calcium antagonists on the cerebral circulation.
    Gelmers HJ
    Am J Cardiol; 1987 Jan; 59(3):173B-176B. PubMed ID: 2433932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of nimodipine on the cerebral blood flow and intracranial pressure.
    Gaab MR; Haubitz I; Brawanski A; Korn A; Czech T
    Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():93-9. PubMed ID: 4010872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of nimodipine on the clinical course of patients with acute ischemic stroke.
    Gelmers HJ
    Acta Neurol Scand; 1984 Apr; 69(4):232-9. PubMed ID: 6377803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of nimodipine, a calcium antagonist with preferential cerebrovascular activity.
    Kazda S
    Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():70-3. PubMed ID: 4010868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium ions and calcium antagonists in ischaemia.
    Symon L; Harris RJ; Branston NM
    Acta Neurochir (Wien); 1982; 63(1-4):267-75. PubMed ID: 7102418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nimodipine: a new calcium antagonistic drug with a preferential cerebrovascular action.
    Kazda S; Towart R
    Acta Neurochir (Wien); 1982; 63(1-4):259-65. PubMed ID: 7102417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments.
    Kazda S; Garthoff B; Krause HP; Schlossmann K
    Arzneimittelforschung; 1982; 32(4):331-8. PubMed ID: 7201801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nimodipine (Bay e 9736) on postischaemic cerebrovascular reactivity, as revealed by measuring regional cerebral blood flow (rCBF).
    Gelmers HJ
    Acta Neurochir (Wien); 1982; 63(1-4):283-90. PubMed ID: 7102420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of nimodipine prophylaxis of cerebral vasospasm on anesthetic management during intracranial aneurysm clipping.
    Stullken EH; Johnston WE; Prough DS; Balestrieri FJ; McWhorter JM
    J Neurosurg; 1985 Feb; 62(2):200-5. PubMed ID: 3881564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of a calcium antagonist, nimodipine, upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischaemia.
    Harris RJ; Branston NM; Symon L; Bayhan M; Watson A
    Stroke; 1982; 13(6):759-66. PubMed ID: 6815837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nimodipine on cerebral functional and metabolic recovery following ischemia in the rat brain.
    Mabe H; Nagai H; Takagi T; Umemura S; Ohno M
    Stroke; 1986; 17(3):501-5. PubMed ID: 3715951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the calcium antagonist nimodipine on the delayed hypoperfusion following incomplete ischemia in the rat.
    Smith ML; Kågström E; Rosén I; Siesjö BK
    J Cereb Blood Flow Metab; 1983 Dec; 3(4):543-6. PubMed ID: 6630325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-channel blockers in the treatment of migraine.
    Gelmers HJ
    Am J Cardiol; 1985 Jan; 55(3):139B-143B. PubMed ID: 3881906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of calcium entry blocker, nimodipine, on the cerebral function and metabolic recovery following experimental cerebral ischemia].
    Mabe H; Takagi T; Umemura S; Ohno M; Nagai H
    No To Shinkei; 1985 Nov; 37(11):1067-72. PubMed ID: 2934079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of dilceren (nimodipine) on the cerebral circulation in the intact animals and animals subjected to ischemic brain damage].
    Aleksandrin VV; Khaĭlov NA; Mirzoian GR; Gan'shina TS
    Eksp Klin Farmakol; 2002; 65(2):17-9. PubMed ID: 12109284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral blood flow and neurologic outcome when nimodipine is given after complete cerebral ischemia in the dog.
    Steen PA; Newberg LA; Milde JH; Michenfelder JD
    J Cereb Blood Flow Metab; 1984 Mar; 4(1):82-7. PubMed ID: 6693515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of calcium antagonists in cerebral arterial spasm.
    Allen GS
    Am J Cardiol; 1985 Jan; 55(3):149B-153B. PubMed ID: 3881907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of gamma 2-melanocyte-stimulating hormone and nimodipine on cortical blood flow and infarction volume in two rat models of middle cerebral artery occlusion.
    Herz RC; De Wildt DJ; Versteeg DH
    Eur J Pharmacol; 1996 Jun; 306(1-3):113-21. PubMed ID: 8813623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nimodipine on intracellular brain pH, cortical blood flow, and EEG in experimental focal cerebral ischemia.
    Meyer FB; Anderson RE; Yaksh TL; Sundt TM
    J Neurosurg; 1986 Apr; 64(4):617-26. PubMed ID: 3950744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.